Results based on real-world studies also indicate that XYSJW can decrease the levels of proinflammatory cytokines IFN-γ, IL-2, and IL-6, while simultaneously increasing the concentration of the anti-inflammatory cytokine IL-10 in the serum of HT patients (Wu, 2023). The gene discussed is IL2; the disease is hematocrit.